Suchergebnisse - "Kameyama, Tsubasa"

PubPharm (8)

1

Does Addition of Protein to Hepatocyte or Microsomal In Vitro Incubations Provide a Useful Improvement in In Vitro-In Vivo Extrapolation Predictability?

enthalten in: Drug metabolism and disposition: the biological fate of chemicals | 2022

von Kameyama, T. | Sodhi, J. | Benet, L.

ErratumIn: Drug Metab Dispos. 2022 Apr;50(4):518. - PMID 35470134

2

Bioanalytical strategies in drug discovery and development

enthalten in: Drug metabolism reviews | 2021

von Thakur, A. | Tan, Z. | Kameyama, T. | +5

3

Bioanalytical strategies in drug discovery and development

enthalten in: Drug metabolism reviews | 2021

von Thakur, A. | Tan, Z. | Kameyama, T. | +5

4

Effect of Timolol on Optineurin Aggregation in Transformed Induced Pluripotent Stem Cells Derived From Patient With Familial Glaucoma

enthalten in: Investigative ophthalmology & visual science | 2018

von Inagaki, S. | Kawase, K. | Funato, M. | +14

RetractionIn: Invest Ophthalmol Vis Sci. 2020 Nov 2;61(13):18. - PMID 33180118

5

Efficacy of Prednisolone in Generated Myotubes Derived From Fibroblasts of Duchenne Muscular Dystrophy Patients

enthalten in: Frontiers in pharmacology | 2018

von Kameyama, T. | Ohuchi, K. | Funato, M. | +13

6

Edaravone is a candidate agent for spinal muscular atrophy : In vitro analysis using a human induced pluripotent stem cells-derived disease model

enthalten in: European journal of pharmacology | 2017

von Ando, S. | Funato, M. | Ohuchi, K. | +8

7

Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog

enthalten in: Stem cells translational medicine | 2016

von Ohuchi, K. | Funato, M. | Kato, Z. | +12

8

Edaravone is a candidate agent for spinal muscular atrophy: in vitro analysis using a human induced pluripotent stem cells-derived disease model

enthalten in: European journal of pharmacology

von Ando, S. | Funato, M. | Ohuchi, K. | +8

1
[1]